Targeting angiogenesis in cancer therapy

Eiki Ichihara, Katsuyuki Kiura, Mitsune Tanimoto

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Angiogenesis is an essential process in tumor growth. The concept of angiogenesis, when proposed by Folksman in 1971, had a great impact on cancer research and therapy, as the survival and proliferation of cancer depend on angiogenesis, which could be a target of cancer therapy. In subsequent decades, numerous antiangiogenic agents were developed, and some of them have been applied clinically. However, angiogenesis includes a complex and multistep process that has not been sufficiently elucidated. In this review, we focus on signaling pathways related with tumor angiogenesis and several antiangiogenic agents approved by the United States Food and Drug Administration or under investigation.

Original languageEnglish
Pages (from-to)353-362
Number of pages10
JournalActa Medica Okayama
Volume65
Issue number6
Publication statusPublished - Dec 22 2011

Fingerprint

Angiogenesis Inhibitors
Tumors
Neoplasms
Therapeutics
United States Food and Drug Administration
Growth
Research

Keywords

  • Angiogenesis
  • Cancer

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Targeting angiogenesis in cancer therapy. / Ichihara, Eiki; Kiura, Katsuyuki; Tanimoto, Mitsune.

In: Acta Medica Okayama, Vol. 65, No. 6, 22.12.2011, p. 353-362.

Research output: Contribution to journalArticle

Ichihara, E, Kiura, K & Tanimoto, M 2011, 'Targeting angiogenesis in cancer therapy', Acta Medica Okayama, vol. 65, no. 6, pp. 353-362.
Ichihara, Eiki ; Kiura, Katsuyuki ; Tanimoto, Mitsune. / Targeting angiogenesis in cancer therapy. In: Acta Medica Okayama. 2011 ; Vol. 65, No. 6. pp. 353-362.
@article{f5af6243a6f44fc29058273925733b4c,
title = "Targeting angiogenesis in cancer therapy",
abstract = "Angiogenesis is an essential process in tumor growth. The concept of angiogenesis, when proposed by Folksman in 1971, had a great impact on cancer research and therapy, as the survival and proliferation of cancer depend on angiogenesis, which could be a target of cancer therapy. In subsequent decades, numerous antiangiogenic agents were developed, and some of them have been applied clinically. However, angiogenesis includes a complex and multistep process that has not been sufficiently elucidated. In this review, we focus on signaling pathways related with tumor angiogenesis and several antiangiogenic agents approved by the United States Food and Drug Administration or under investigation.",
keywords = "Angiogenesis, Cancer",
author = "Eiki Ichihara and Katsuyuki Kiura and Mitsune Tanimoto",
year = "2011",
month = "12",
day = "22",
language = "English",
volume = "65",
pages = "353--362",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "6",

}

TY - JOUR

T1 - Targeting angiogenesis in cancer therapy

AU - Ichihara, Eiki

AU - Kiura, Katsuyuki

AU - Tanimoto, Mitsune

PY - 2011/12/22

Y1 - 2011/12/22

N2 - Angiogenesis is an essential process in tumor growth. The concept of angiogenesis, when proposed by Folksman in 1971, had a great impact on cancer research and therapy, as the survival and proliferation of cancer depend on angiogenesis, which could be a target of cancer therapy. In subsequent decades, numerous antiangiogenic agents were developed, and some of them have been applied clinically. However, angiogenesis includes a complex and multistep process that has not been sufficiently elucidated. In this review, we focus on signaling pathways related with tumor angiogenesis and several antiangiogenic agents approved by the United States Food and Drug Administration or under investigation.

AB - Angiogenesis is an essential process in tumor growth. The concept of angiogenesis, when proposed by Folksman in 1971, had a great impact on cancer research and therapy, as the survival and proliferation of cancer depend on angiogenesis, which could be a target of cancer therapy. In subsequent decades, numerous antiangiogenic agents were developed, and some of them have been applied clinically. However, angiogenesis includes a complex and multistep process that has not been sufficiently elucidated. In this review, we focus on signaling pathways related with tumor angiogenesis and several antiangiogenic agents approved by the United States Food and Drug Administration or under investigation.

KW - Angiogenesis

KW - Cancer

UR - http://www.scopus.com/inward/record.url?scp=84858256112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858256112&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 353

EP - 362

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 6

ER -